Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Anton

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Infectious Diseases|December 8, 1998
Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitroM D Miller, K E Anton, A S Mulato, et al.
Journal of Neuroscience Methods|December 7, 2002
Specific interference with gene expression and gene function mediated by long dsRNA in neural cellsL Gan, K E Anton, B A Masterson, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapyA S Mulato, P D Lamy, M D Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408M D Miller, N A Margot, P D Lamy, et al.
Antiviral Therapy|February 22, 2000
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPAM A Wainberg, M D Miller, Y Quan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Infectious Diseases|December 8, 1998
Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitroM D Miller, K E Anton, A S Mulato, et al.
Journal of Neuroscience Methods|December 7, 2002
Specific interference with gene expression and gene function mediated by long dsRNA in neural cellsL Gan, K E Anton, B A Masterson, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapyA S Mulato, P D Lamy, M D Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408M D Miller, N A Margot, P D Lamy, et al.
Antiviral Therapy|February 22, 2000
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPAM A Wainberg, M D Miller, Y Quan, et al.
Pageof 1